Impact of Covid-19 on Gene Therapy Cell Culture Media market 2020 [ PDF ] with CAGR of the End 2029 | HiMedia Ltd., Thermo Fischer Scientific, Lonza

Gene Therapy Cell Culture Media Market

The gene therapy cell culture media market was valued at 152.67 million in 2019 and is expected to record a CAGR of 10.87% during the forecast period, 2020–2029.

The utility of cell culture media stands as a platform to grow and modify genes and incorporate them by replacing damaged tissue or the default gene. In gene therapy, cell culture media technology is carried out by utilizing adult cells that are genetically reprogrammed and capable of becoming one of the main types of cells incorporated inside the patient's body. This technique helps to develop limitless specific human cells needed for therapeutic purposes. For instance, recently developed CAR-T cells are genetically modified before reintroducing it in the patient's body. Similarly, gene therapy using AAV vector delivers high activity Factor 9 gene to the liver for treating hemophilia B.

Gene therapy and cell culture media refer to an experimental technique used for treating or preventing diseases. The technique includes replacing a default gene with a healthy gene and inactivating the function of the faulty gene. Cell culture media is composed of appropriate levels of amino acids, inorganic salts, vitamins, glucose, and serum, among others. The media requires additional supplementary reagents and sera such as hormones, growth factors, trace elements, lipids, and minerals for the cell cultures to grow and survive in the incubation environment.
The market's most prominent driver is the increased funding for R&D activities on gene therapy cell culture media. For instance, on April 11th, 2019: Asklepios Biopharmaceutical Inc. invested about USD 235 million in R&D activities for performing extensive clinical trials of gene therapy.

FDA is also channelizing efforts to develop innovative technologies that integrate genome editing technology, novel gene delivery method, and advanced manufacturing technology in the field of gene therapy and cell culture media. It is collaborating with leading players to foster the development of transformational technology that facilitates the manufacturing of safe and effective gene therapy products with therapeutic interventions. Similarly, the National Institute of Health (NIH) is one of the pioneers in gene therapy.

Rising R&D activities in novel gene therapy cell culture media are bolstering the advent of a wide variety of treatments for a number of challenging diseases. For instance, on May 24th, 2019: Novartis developed the novel technique of gene therapy that uses a recombinant AAV9 vector to deliver a specific gene, which is currently in development as a one-time treatment for spinal muscular atrophy (SMA). It will have the potential to prevent further muscular degeneration by addressing the primary defective SMN gene. Similarly, on September 10th, 2018, Stargen developed the novel treatment of gene therapy for the treatment of Stargardt disease (juvenile-onset macular dystrophy) delivers a corrected version of the ABCR gene directly in the photoreceptor of the retina.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/gene-therapy-cell-culture-media-market/request-sample

The Major Prominent Players Covered in this Report:
HiMedia Ltd.
Thermo Fischer Scientific
Lonza
Sartorius AG
R&D Systems Inc.(Bio-Techne)
GE Healthcare
Fujifilm Irvine Scientific

By Type: Lysogeny Broth, Chemically defined media, Serum free media, Specialty media, Stem cell media, Custom media, Others
By End User: Pharmaceutical & Biotechnology companies, Academic institutions, Research laboratories, Others

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post the COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Steerable Medical Devices in these regions, from 2020 to 2029, covering:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

View this report with a detailed description and TOC @ https://straitsresearch.com/report/gene-therapy-cell-culture-media-market/toc

Key Gene Therapy Cell Culture Media Market Trends:
- The report identifies, determines, and forecasts the Global Gene Therapy Cell Culture Media Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Gene Therapy Cell Culture Media Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Gene Therapy Cell Culture Media Market.

Key Questions Answered in The Report:
What will the Gene Therapy Cell Culture Media market growth rate?
What are the key factors driving the global Gene Therapy Cell Culture Media market?
Who are the key manufacturers in the Gene Therapy Cell Culture Media market space?
What are the market opportunities, market risk, and market overview of the Gene Therapy Cell Culture Media market?
What are sales, revenue, and price analysis of top manufacturers of the Gene Therapy Cell Culture Media market?
Who are the distributors, traders, and dealers of the Gene Therapy Cell Culture Media market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Gene Therapy Cell Culture Media Industry?
What are sales, revenue, and price analysis by regions of Gene Therapy Cell Culture Media industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Recent Developments:
On August 21st, 2019, Pfizer invested USD 500 million for establishing new manufacturing and research facilities for gene therapy in Stanford, North Carolina.

On January 28th, 2020, FDA announced the Orphan Drug Regulation, which involves guidance on gene therapy manufacturing and clinical development of products, interpretation, and maintaining similarity of gene therapy products

On November 12th, 2019, Merck signed a license agreement with Evotec SE. The agreement provides Evotec access to Merck's foundational CRISPR intellectual property rights

On May 6th, 2013, Roche and BioLamina signed an R&D agreement to jointly develop new cell culture systems for various applications that highly integrates stem cell research. As per the agreement, Roche will offer R&D funding and scientific expertise to BioLamina

On April 10th, 2018, Lonza Group Ltd. established a new manufacturing facility in the U.S. to increase its production capacity in terms of viral gene and virally modified cell therapy products
On June 17th, 2015, WuXi AppTec's partnered with the University of Pennysylvania to develop viral vectors in gene therapy

Browse Full Report @ 
https://straitsresearch.com/report/gene-therapy-cell-culture-media-market

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/gene-therapy-cell-culture-media-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs.

This release was published on openPR.